{"id":60005,"date":"2026-06-04T22:55:26","date_gmt":"2026-06-04T13:55:26","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4883\/"},"modified":"2026-08-09T14:06:50","modified_gmt":"2026-08-09T05:06:50","slug":"company-4883","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4883\/","title":{"rendered":"MODALIS THERAPEUTICS CORP"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4883","DATE":"2026-01-09","longName":"Modalis Therapeutics Corporation","company_name_ja":"","fullTimeEmployees":17,"address":"","phone":"","website":"https:\/\/modalistx.com","industry":"Drug Manufacturers - Specialty & Generic","sector":"Healthcare","regularMarketPrice":61,"financialCurrency":"","marketCap":4692,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":-2211800000,"operatingMargins":0,"NetIncome":-2152710000,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":-77.069999999999993,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"Modalis Therapeutics Corporation engages in the research and development of therapeutics to treat patients with serious genetic disorders. The company is developing therapies for genetic diseases using its proprietary CRISPR-GNDM an epigenome editing technology that combines dCas9. It also develops various therapeutics for muscle disorders, cardiomyopathy, and CNS disorders. The company was formerly known as EdiGENE Corporation and changed its name to Modalis Therapeutics Corporation in August 2019. Modalis Therapeutics Corporation was incorporated in 2016 and is headquartered in Chuo, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-09T02:18:49.615976\", \"ticker\": \"4883\", \"ticker_full\": \"4883.T\", \"company_name\": \"MODALIS THERAPEUTICS CORP\", \"company_info\": {\"name_en\": \"MODALIS THERAPEUTICS CORP\", \"long_name\": \"Modalis Therapeutics Corporation\", \"sector\": \"Healthcare\", \"industry\": \"Drug Manufacturers - Specialty & Generic\", \"website\": \"https:\/\/modalistx.com\", \"employees\": 17, \"country\": \"Japan\", \"city\": \"Chuo\", \"address\": \"Nihonbashi-Lifescience-Bldg.2\", \"description\": \"Modalis Therapeutics Corporation engages in the research and development of therapeutics to treat patients with serious genetic disorders. The company is developing therapies for genetic diseases using its proprietary CRISPR-GNDM an epigenome editing technology that combines dCas9. It also develops various therapeutics for muscle disorders, cardiomyopathy, and CNS disorders. The company was formerly known as EdiGENE Corporation and changed its name to Modalis Therapeutics Corporation in August 2019. Modalis Therapeutics Corporation was incorporated in 2016 and is headquartered in Chuo, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 31.6, \"deviation\": 1.27, \"trend\": \"up\"}, \"ma_25\": {\"ma_value\": 32.48, \"deviation\": -1.48, \"trend\": \"down\"}, \"ma_75\": {\"ma_value\": 42.87, \"deviation\": -25.35, \"trend\": \"down\"}, \"ma_200\": {\"ma_value\": 54.88, \"deviation\": -41.69, \"trend\": \"down\"}}, \"financials\": {\"years\": [{\"year\": 2025, \"revenue\": 0.0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -2211800000.0, \"operating_income_fmt\": \"-\u00a522\u5104\", \"ebit\": -2148366000.0, \"ebit_fmt\": \"-\u00a521\u5104\", \"net_income\": -2152710000.0, \"net_income_fmt\": \"-\u00a522\u5104\", \"eps\": 0, \"operating_margin\": 0, \"total_assets\": 2964248000.0, \"total_assets_fmt\": \"\u00a530\u5104\", \"total_equity\": 2793304000.0, \"total_equity_fmt\": \"\u00a528\u5104\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 2812367000.0, \"total_cash_fmt\": \"\u00a528\u5104\", \"equity_ratio\": 94.23, \"de_ratio\": 0.0, \"current_ratio\": 21.46, \"operating_cf\": -2118409000.0, \"operating_cf_fmt\": \"-\u00a521\u5104\", \"investing_cf\": -2571000.0, \"investing_cf_fmt\": \"-\u00a52.6M\", \"financing_cf\": 1351037000.0, \"financing_cf_fmt\": \"\u00a514\u5104\", \"free_cf\": -2120980000.0, \"free_cf_fmt\": \"-\u00a521\u5104\", \"net_margin\": 0, \"roe\": -77.07, \"roa\": -72.62}, {\"year\": 2024, \"revenue\": 0.0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -1337650000.0, \"operating_income_fmt\": \"-\u00a513\u5104\", \"ebit\": -1313072000.0, \"ebit_fmt\": \"-\u00a513\u5104\", \"net_income\": -1317894000.0, \"net_income_fmt\": \"-\u00a513\u5104\", \"eps\": -28.57, \"operating_margin\": 0, \"total_assets\": 3691549000.0, \"total_assets_fmt\": \"\u00a537\u5104\", \"total_equity\": 3548077000.0, \"total_equity_fmt\": \"\u00a535\u5104\", \"total_debt\": 0.0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 3575277000.0, \"total_cash_fmt\": \"\u00a536\u5104\", \"equity_ratio\": 96.11, \"de_ratio\": 0.0, \"current_ratio\": 30.83, \"operating_cf\": -1432005000.0, \"operating_cf_fmt\": \"-\u00a514\u5104\", \"investing_cf\": -188000.0, \"investing_cf_fmt\": \"-\u00a5188,000\", \"financing_cf\": 3044985000.0, \"financing_cf_fmt\": \"\u00a530\u5104\", \"free_cf\": -1432193000.0, \"free_cf_fmt\": \"-\u00a514\u5104\", \"net_margin\": 0, \"roe\": -37.14, \"roa\": -35.7}, {\"year\": 2023, \"revenue\": 0.0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -2370665000.0, \"operating_income_fmt\": \"-\u00a524\u5104\", \"ebit\": -2386193000.0, \"ebit_fmt\": \"-\u00a524\u5104\", \"net_income\": -2391821000.0, \"net_income_fmt\": \"-\u00a524\u5104\", \"eps\": -77.24, \"operating_margin\": 0, \"total_assets\": 2025925000.0, \"total_assets_fmt\": \"\u00a520\u5104\", \"total_equity\": 1380422000.0, \"total_equity_fmt\": \"\u00a514\u5104\", \"total_debt\": 412500000.0, \"total_debt_fmt\": \"\u00a54\u5104\", \"total_cash\": 1883437000.0, \"total_cash_fmt\": \"\u00a519\u5104\", \"equity_ratio\": 68.14, \"de_ratio\": 0.3, \"current_ratio\": 9.88, \"operating_cf\": -2254466000.0, \"operating_cf_fmt\": \"-\u00a523\u5104\", \"investing_cf\": -39699000.0, \"investing_cf_fmt\": \"-\u00a539.7M\", \"financing_cf\": 1216451000.0, \"financing_cf_fmt\": \"\u00a512\u5104\", \"free_cf\": -2294165000.0, \"free_cf_fmt\": \"-\u00a523\u5104\", \"net_margin\": 0, \"roe\": -173.27, \"roa\": -118.06}, {\"year\": 2022, \"revenue\": 40500000.0, \"revenue_fmt\": \"\u00a540.5M\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -2063194000.0, \"operating_income_fmt\": \"-\u00a521\u5104\", \"ebit\": -2702208000.0, \"ebit_fmt\": \"-\u00a527\u5104\", \"net_income\": -2702709000.0, \"net_income_fmt\": \"-\u00a527\u5104\", \"eps\": -92.85, \"operating_margin\": -5094.31, \"total_assets\": 3129833000.0, \"total_assets_fmt\": \"\u00a531\u5104\", \"total_equity\": 2941232000.0, \"total_equity_fmt\": \"\u00a529\u5104\", \"total_debt\": 0.0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 2933162000.0, \"total_cash_fmt\": \"\u00a529\u5104\", \"equity_ratio\": 93.97, \"de_ratio\": 0.0, \"current_ratio\": 21.58, \"operating_cf\": -1895773000.0, \"operating_cf_fmt\": \"-\u00a519\u5104\", \"investing_cf\": -185719000.0, \"investing_cf_fmt\": \"-\u00a52\u5104\", \"financing_cf\": 63683000.0, \"financing_cf_fmt\": \"\u00a563.7M\", \"free_cf\": -2093060000.0, \"free_cf_fmt\": \"-\u00a521\u5104\", \"net_margin\": -6673.36, \"roe\": -91.89, \"roa\": -86.35}, {\"year\": 2021, \"revenue\": 0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": 0, \"operating_income_fmt\": \"N\/A\", \"ebit\": 0, \"ebit_fmt\": \"N\/A\", \"net_income\": 0, \"net_income_fmt\": \"N\/A\", \"eps\": -25.7, \"operating_margin\": 0, \"total_assets\": 0, \"total_assets_fmt\": \"N\/A\", \"total_equity\": 0, \"total_equity_fmt\": \"N\/A\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 0, \"total_cash_fmt\": \"N\/A\", \"equity_ratio\": 0, \"de_ratio\": 0, \"current_ratio\": 0, \"operating_cf\": 0, \"operating_cf_fmt\": \"N\/A\", \"investing_cf\": 0, \"investing_cf_fmt\": \"N\/A\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": 0, \"free_cf_fmt\": \"N\/A\", \"net_margin\": 0, \"roe\": 0, \"roa\": 0}], \"has_data\": true}, \"dividends\": {\"history\": [], \"has_data\": false}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-60005","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>MODALIS THERAPEUTICS CORP - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4883\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4883\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4883\/\",\"name\":\"MODALIS THERAPEUTICS CORP - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-06-04T13:55:26+00:00\",\"dateModified\":\"2026-08-09T05:06:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4883\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4883\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4883\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MODALIS THERAPEUTICS CORP\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MODALIS THERAPEUTICS CORP - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4883\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4883\/","url":"https:\/\/japanir.jp\/en\/company\/company-4883\/","name":"MODALIS THERAPEUTICS CORP - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-06-04T13:55:26+00:00","dateModified":"2026-08-09T05:06:50+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4883\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4883\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4883\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"MODALIS THERAPEUTICS CORP"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/60005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=60005"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=60005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}